These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 2339131

  • 1. 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice.
    Zhou JY, Norman AW, Chen DL, Sun GW, Uskokovic M, Koeffler HP.
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3929-32. PubMed ID: 2339131
    [Abstract] [Full Text] [Related]

  • 2. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
    Norman AW, Zhou JY, Henry HL, Uskokovic MR, Koeffler HP.
    Cancer Res; 1990 Nov 01; 50(21):6857-64. PubMed ID: 2208153
    [Abstract] [Full Text] [Related]

  • 3. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships.
    Bischof MG, Redlich K, Schiller C, Chirayath MV, Uskokovic M, Peterlik M, Cross HS.
    J Pharmacol Exp Ther; 1995 Dec 01; 275(3):1254-60. PubMed ID: 8531089
    [Abstract] [Full Text] [Related]

  • 4. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
    Aparna R, Subhashini J, Roy KR, Reddy GS, Robinson M, Uskokovic MR, Venkateswara Reddy G, Reddanna P.
    J Cell Biochem; 2008 Aug 01; 104(5):1832-42. PubMed ID: 18348265
    [Abstract] [Full Text] [Related]

  • 5. Metabolism of the cell differentiating agent 1alpha,25(OH)2-16-ene-23-yne vitamin D3 by leukemic cells.
    Satchell DP, Norman AW.
    J Steroid Biochem Mol Biol; 1996 Jan 01; 57(1-2):117-24. PubMed ID: 8645610
    [Abstract] [Full Text] [Related]

  • 6. 1alpha,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1alpha,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells.
    Siu-Caldera ML, Clark JW, Santos-Moore A, Peleg S, Liu YY, Uskoković MR, Sharma S, Reddy GS.
    J Steroid Biochem Mol Biol; 1996 Dec 01; 59(5-6):405-12. PubMed ID: 9010346
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP.
    Cancer Res; 1998 Aug 01; 58(15):3370-5. PubMed ID: 9699668
    [Abstract] [Full Text] [Related]

  • 10. Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels.
    Pakkala S, de Vos S, Elstner E, Rude RK, Uskokovic M, Binderup L, Koeffler HP.
    Leuk Res; 1995 Jan 01; 19(1):65-72. PubMed ID: 7837819
    [Abstract] [Full Text] [Related]

  • 11. Antileukemic effect of a synthetic vitamin D3 analog, HY-11, with low potential to cause hypercalcemia.
    Yoon JS, Kim JY, Park HK, Kim ES, Ahn KS, Yoon SS, Cho CG, Kim BK, Lee YY.
    Int J Oncol; 2008 Feb 01; 32(2):387-96. PubMed ID: 18202761
    [Abstract] [Full Text] [Related]

  • 12. 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivo.
    Schwartz GG, Hill CC, Oeler TA, Becich MJ, Bahnson RR.
    Urology; 1995 Sep 01; 46(3):365-9. PubMed ID: 7660511
    [Abstract] [Full Text] [Related]

  • 13. Antineoplastic effect and toxicity of 1,25-dihydroxy-16-ene-23-yne-vitamin D3 in athymic mice with Y-79 human retinoblastoma tumors.
    Sabet SJ, Darjatmoko SR, Lindstrom MJ, Albert DM.
    Arch Ophthalmol; 1999 Mar 01; 117(3):365-70. PubMed ID: 10088815
    [Abstract] [Full Text] [Related]

  • 14. Potent antiproliferative effects of 25-hydroxy-16-ene-23-yne-vitamin D₃ that resists the catalytic activity of both CYP27B1 and CYP24A1.
    Rhieu SY, Annalora AJ, LaPorta E, Welsh J, Itoh T, Yamamoto K, Sakaki T, Chen TC, Uskokovic MR, Reddy GS.
    J Cell Biochem; 2014 Aug 01; 115(8):1392-402. PubMed ID: 24535953
    [Abstract] [Full Text] [Related]

  • 15. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
    Hisatake J, Kubota T, Hisatake Y, Uskokovic M, Tomoyasu S, Koeffler HP.
    Cancer Res; 1999 Aug 15; 59(16):4023-9. PubMed ID: 10463602
    [Abstract] [Full Text] [Related]

  • 16. In vivo and in vitro effect of 1,25-dihydroxyvitamin D3 and 1,25-dihydroxy-16-ene-23-yne-vitamin D3 on the proliferation and differentiation of avian chondrocytes: their role in tibial dyschondroplasia.
    Farquharson C, Rennie JS, Loveridge N, Whitehead CC.
    J Endocrinol; 1996 Mar 15; 148(3):465-74. PubMed ID: 8778225
    [Abstract] [Full Text] [Related]

  • 17. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP.
    Anticancer Res; 1999 Mar 15; 19(3A):1689-97. PubMed ID: 10470102
    [Abstract] [Full Text] [Related]

  • 18. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3.
    Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Uskokovic MR, Brenner RV, Evans SR.
    Cancer Res; 1994 Aug 01; 54(15):4057-64. PubMed ID: 8033137
    [Abstract] [Full Text] [Related]

  • 19. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW, Sergeev IN, Bishop JE, Okamura WH.
    Cancer Res; 1993 Sep 01; 53(17):3935-42. PubMed ID: 8395333
    [Abstract] [Full Text] [Related]

  • 20. Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization.
    Zhou JY, Norman AW, Lübbert M, Collins ED, Uskokovic MR, Koeffler HP.
    Blood; 1989 Jul 01; 74(1):82-93. PubMed ID: 2665845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.